A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...
Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback